Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition
Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in...
Saved in:
Published in | Cancers Vol. 12; no. 8; p. 2300 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
15.08.2020
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells. |
---|---|
AbstractList | Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells. Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells.Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-β-cyclodextrin (MβCD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells. Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer (PCa). We aimed to determine the role of exosomal ITGA2 derived from castration-resistant PCa (CRPC) cells in promoting aggressive phenotypes in androgen receptor (AR)-positive cells. Exosomes were co-incubated with recipient cells and tested for different cellular assays. ITGA2 was enriched in exosomes derived from CRPC cells. Co-culture of AR-positive cells with CRPC-derived exosomes increased their proliferation, migration, and invasion by promoting epithelial-mesenchymal transition, which was reversed via ITGA2 knockdown or inhibition of exosomal uptake by methyl-[beta]-cyclodextrin (M[beta]CD). Ectopic expression of ITGA2 reproduced the effect of exosomal ITGA2 in PCa cells. ITGA2 transferred by exosomes exerted its effect within a shorter time compared to that triggered by its endogenous expression. The difference of ITGA2 protein expression in localized tumors and those with lymph node metastatic tissues was indistinguishable. Nevertheless, its abundance was higher in circulating exosomes collected from PCa patients when compared with normal subjects. Our findings indicate the possible role of the exosomal-ITGA2 transfer in altering the phenotype of AR-positive cells towards more aggressive phenotype. Thus, interfering with exosomal cargo transfer may inhibit the development of aggressive phenotype in PCa cells. |
Audience | Academic |
Author | Gaballa, Rofaida Salem, Heba F. Ali, Hamdy E. A. Rhim, Johng S. Kandeil, Mohamed A. Saleem, Mohammad Ambs, Stefan Ali, Hamed I. Abd Elmageed, Zakaria Y. Mahmoud, Mohamed O. |
AuthorAffiliation | 1 Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M Health Science Center, College Station, TX 77843, USA; Rofayda011142@pharm.bsu.edu.eg (R.G.); haali@tamu.edu (H.E.A.A.); alyismail@tamu.edu (H.I.A.) 3 Department of Radiobiological Applications, Nuclear Research Center, Atomic Energy Authority, Cairo 13759, Egypt 5 Department of Pharmaceutics, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62521, Egypt; heba_salem2004@yahoo.co.uk 2 Departments of Biochemistry, Faculty of Pharmacy, Beni-Suef University; Beni-Suef 62521, Egypt; mohamed.omar@pharm.bsu.edu.eg 4 Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; jrhim@verizon.net 8 Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA; ambss@mail.nih.gov 9 Department of Pharmacology, Edward Via College of Osteopathic Medicine, University of Louisiana at Monroe, Monroe, LA 71203, USA 6 Department of |
AuthorAffiliation_xml | – name: 3 Department of Radiobiological Applications, Nuclear Research Center, Atomic Energy Authority, Cairo 13759, Egypt – name: 1 Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M Health Science Center, College Station, TX 77843, USA; Rofayda011142@pharm.bsu.edu.eg (R.G.); haali@tamu.edu (H.E.A.A.); alyismail@tamu.edu (H.I.A.) – name: 5 Department of Pharmaceutics, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62521, Egypt; heba_salem2004@yahoo.co.uk – name: 9 Department of Pharmacology, Edward Via College of Osteopathic Medicine, University of Louisiana at Monroe, Monroe, LA 71203, USA – name: 4 Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; jrhim@verizon.net – name: 7 Department of Biochemistry, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef 62521, Egypt; mohamedkandeel561@yahoo.com – name: 8 Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA; ambss@mail.nih.gov – name: 6 Department of Urology, Masonic Cancer Center, University of Minnesota, Minnesota, MN 55455, USA; msbhat@umn.edu – name: 2 Departments of Biochemistry, Faculty of Pharmacy, Beni-Suef University; Beni-Suef 62521, Egypt; mohamed.omar@pharm.bsu.edu.eg |
Author_xml | – sequence: 1 givenname: Rofaida orcidid: 0000-0003-1387-2118 surname: Gaballa fullname: Gaballa, Rofaida – sequence: 2 givenname: Hamdy E. A. orcidid: 0000-0003-3290-1623 surname: Ali fullname: Ali, Hamdy E. A. – sequence: 3 givenname: Mohamed O. surname: Mahmoud fullname: Mahmoud, Mohamed O. – sequence: 4 givenname: Johng S. surname: Rhim fullname: Rhim, Johng S. – sequence: 5 givenname: Hamed I. surname: Ali fullname: Ali, Hamed I. – sequence: 6 givenname: Heba F. surname: Salem fullname: Salem, Heba F. – sequence: 7 givenname: Mohammad orcidid: 0000-0002-7422-7967 surname: Saleem fullname: Saleem, Mohammad – sequence: 8 givenname: Mohamed A. surname: Kandeil fullname: Kandeil, Mohamed A. – sequence: 9 givenname: Stefan surname: Ambs fullname: Ambs, Stefan – sequence: 10 givenname: Zakaria Y. orcidid: 0000-0003-4031-0348 surname: Abd Elmageed fullname: Abd Elmageed, Zakaria Y. |
BookMark | eNp1kstu3CAUhlGVqknTrLtF6qYbJ1xsbDaVotG0GSlRu0jXCHPxENkwBRxlXqFPXZyJehmpbOCI7__POXDeghMfvAHgPUaXlHJ0paRXJiZMUEcoQq_AGUEtqRjj9clf51NwkdIDKotS3LL2DTilpCM1oc0Z-Ll-CilMJlV3RjuZjYb3UfpkTYTBwk0eJIHfYphCNgneuSHK7IKH0mu48Y8yLUEBC5JykcPVc1FwZcYxwX5fID0r5we43rm8NaOTY0mVjFfb_STHQza3eL4Dr60ck7l42c_B98_r-9VNdfv1y2Z1fVupmpNcMamUNlxbzDmyiGDSNwgRiRWpO037VrdKYUt6Urdtj01jW2S1rHlHGeHG0nPw6eC7m_vJaGV8jnIUu-gmGfciSCf-vfFuK4bwKNqaMYxpMfj4YhDDj9mkLCaXVGlYehPmJEhNWY0Qb5qCfjhCH8IcfWlvoRqGSFPzP9QgRyOct6HkVYupuGaUc8abtivU1YFS5a1TNPZ3yRiJZSDE0UAURXOkUC4__1_xd-N_db8AEUm-Ag |
CitedBy_id | crossref_primary_10_1016_j_jksus_2023_102864 crossref_primary_10_1016_j_prp_2022_154024 crossref_primary_10_3389_fnmol_2021_809878 crossref_primary_10_1186_s40364_022_00398_w crossref_primary_10_3390_cancers13205236 crossref_primary_10_3390_biom14080990 crossref_primary_10_3389_fbioe_2024_1444201 crossref_primary_10_1007_s12672_024_01183_x crossref_primary_10_1016_j_critrevonc_2021_103565 crossref_primary_10_1111_and_14079 crossref_primary_10_1186_s12935_023_02935_5 crossref_primary_10_1186_s13045_022_01305_4 crossref_primary_10_20517_cdr_2023_17 crossref_primary_10_3390_cancers16132462 crossref_primary_10_1002_mco2_70009 crossref_primary_10_3390_ijms22073528 crossref_primary_10_3390_cells10051029 crossref_primary_10_3390_cells11091375 crossref_primary_10_3389_fcell_2021_679527 crossref_primary_10_3389_fmolb_2021_708779 crossref_primary_10_1016_j_addr_2023_115054 crossref_primary_10_1016_j_jconrel_2023_07_059 crossref_primary_10_62347_XXXA3182 crossref_primary_10_1016_j_semcancer_2021_08_004 crossref_primary_10_62347_JWMX3035 crossref_primary_10_3389_fgene_2023_1045061 crossref_primary_10_3390_ijms22042193 crossref_primary_10_12677_ACM_2020_1012436 crossref_primary_10_1038_s41388_021_01948_6 crossref_primary_10_1515_cclm_2020_1685 crossref_primary_10_3390_biomedicines12010079 crossref_primary_10_1016_j_heliyon_2023_e23553 crossref_primary_10_1016_j_critrevonc_2024_104348 crossref_primary_10_7554_eLife_59442 crossref_primary_10_1038_s41586_022_04833_8 crossref_primary_10_1186_s12951_023_02219_0 crossref_primary_10_1016_j_prp_2024_155484 crossref_primary_10_1016_j_jddst_2022_103856 crossref_primary_10_1007_s13402_022_00731_3 crossref_primary_10_1080_14728222_2023_2293757 crossref_primary_10_1002_minf_202060040 crossref_primary_10_1007_s11010_023_04715_1 crossref_primary_10_1016_j_canlet_2022_215809 crossref_primary_10_1080_21691401_2023_2238756 crossref_primary_10_1038_s41580_024_00777_1 crossref_primary_10_1186_s12951_025_03326_w crossref_primary_10_1016_j_cpt_2024_04_005 |
Cites_doi | 10.1002/ijc.26224 10.1038/nature15756 10.1038/nrclinonc.2014.87 10.1002/pros.23446 10.3390/cancers12071870 10.1186/s13058-016-0725-1 10.3390/cells9030564 10.1158/1078-0432.CCR-16-2180 10.1158/1541-7786.MCR-16-0058 10.1158/1541-7786.MCR-08-0400 10.1371/journal.pone.0024234 10.1016/j.ceb.2011.03.014 10.1016/S0002-9440(10)63112-4 10.1371/journal.pone.0135128 10.1158/0008-5472.CAN-16-0543 10.1038/35094009 10.3390/cells9040861 10.1038/srep40464 10.3322/caac.21590 10.1093/carcin/bgt156 10.1038/s41568-018-0038-z 10.1158/0008-5472.CAN-08-2764 10.1158/1055-9965.EPI-18-1132 10.14348/molcells.2016.0210 10.1158/0008-5472.CAN-05-4000 10.1186/s12575-018-0073-x 10.1016/j.matbio.2018.05.002 10.1038/s41598-018-34637-8 10.1186/s13046-019-1496-1 10.3389/fonc.2020.00308 10.1158/0008-5472.CAN-08-0249 10.1016/j.semcancer.2017.02.006 10.1016/j.tcb.2014.12.006 10.1016/j.euf.2017.10.014 10.3390/cancers11101418 10.3402/jev.v2i0.22097 10.1074/jbc.M112.445403 10.1038/nature14492 10.1084/jem.20190158 10.1002/stem.1619 10.1073/pnas.86.24.9906 10.1155/2015/481493 10.1016/j.jamcollsurg.2017.12.040 10.1158/0008-5472.CAN-17-2341 10.20517/2394-4722.2017.32 10.1056/NEJMp048178 10.1038/nm972 10.1016/j.matbio.2018.08.004 10.1016/0046-8177(93)90033-D 10.1186/s12943-016-0523-5 10.1186/1476-4598-13-208 10.2217/fon.10.48 10.1677/ERC-08-0019 10.1002/cncr.10788 10.4103/1477-3163.48453 10.1593/neo.08380 10.1210/en.2013-1971 10.1016/j.matbio.2018.03.009 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 MDPI AG 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 by the authors. 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 MDPI AG – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 by the authors. 2020 |
DBID | AAYXX CITATION 3V. 7T5 7TO 7XB 8FE 8FH 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ GUQSH H94 HCIFZ LK8 M2O M7P MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.3390/cancers12082300 |
DatabaseName | CrossRef ProQuest Central (Corporate) Immunology Abstracts Oncogenes and Growth Factors Abstracts ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection (ProQuest) ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Biological Science Collection Research Library Biological Science Database Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2072-6694 |
ExternalDocumentID | PMC7466113 A639969578 10_3390_cancers12082300 |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- 53G 5VS 8FE 8FH 8G5 AADQD AAFWJ AAYXX ABDBF ABUWG ACUHS ADBBV AFKRA AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION DIK DWQXO E3Z EBD ESX GNUQQ GUQSH GX1 HCIFZ HYE IAO IHR KQ8 LK8 M2O M48 M7P MODMG M~E OK1 P6G PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RPM TUS 3V. 7T5 7TO 7XB 8FK H94 MBDVC PKEHL PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c492t-6accde9df1990f0212b5002a1c248d3b7d7cc1f2b2477b1e5f70fda4983629ef3 |
IEDL.DBID | M48 |
ISSN | 2072-6694 |
IngestDate | Thu Aug 21 14:11:33 EDT 2025 Thu Jul 10 18:33:26 EDT 2025 Fri Jul 25 11:51:35 EDT 2025 Tue Jun 17 21:31:06 EDT 2025 Tue Jul 01 01:52:02 EDT 2025 Thu Apr 24 23:04:47 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c492t-6accde9df1990f0212b5002a1c248d3b7d7cc1f2b2477b1e5f70fda4983629ef3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-4031-0348 0000-0003-1387-2118 0000-0002-7422-7967 0000-0003-3290-1623 |
OpenAccessLink | https://www.proquest.com/docview/2435602549?pq-origsite=%requestingapplication% |
PMID | 32824235 |
PQID | 2435602549 |
PQPubID | 2032421 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7466113 proquest_miscellaneous_2436400955 proquest_journals_2435602549 gale_infotracmisc_A639969578 crossref_primary_10_3390_cancers12082300 crossref_citationtrail_10_3390_cancers12082300 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20200815 |
PublicationDateYYYYMMDD | 2020-08-15 |
PublicationDate_xml | – month: 8 year: 2020 text: 20200815 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | Cancers |
PublicationYear | 2020 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Ren (ref_26) 2019; 38 Hu (ref_8) 2009; 69 Antonarakis (ref_14) 2016; 14 Cox (ref_18) 2015; 522 Hooker (ref_32) 2019; 28 ref_52 Obinata (ref_34) 2012; 130 Reis (ref_50) 2009; 8 Hoshino (ref_20) 2015; 527 ref_17 Li (ref_48) 2017; 7 Ziaee (ref_38) 2014; 13 Siegel (ref_1) 2020; 70 Stanbrough (ref_9) 2006; 66 Ryu (ref_49) 2016; 39 Cheville (ref_4) 2002; 95 Singh (ref_42) 2016; 14 Allott (ref_55) 2016; 18 Bijnsdorp (ref_43) 2013; 2 Robinson (ref_56) 2011; 23 Bonkhoff (ref_15) 2018; 78 Hutchinson (ref_3) 2014; 11 ref_21 Krishn (ref_40) 2019; 77 McAtee (ref_46) 2019; 78 Kelly (ref_13) 2018; 4 Mirzapoiazova (ref_58) 2015; 2015 ref_28 Hamidi (ref_35) 2018; 18 Bonkhoff (ref_51) 1993; 24 Feldman (ref_12) 2001; 1 Seguin (ref_23) 2015; 25 Dai (ref_47) 2019; 216 Elmageed (ref_29) 2014; 32 Elices (ref_25) 1989; 86 Xiao (ref_22) 2018; 78 Karpf (ref_33) 2009; 7 ref_31 Goel (ref_24) 2008; 15 Svensson (ref_45) 2013; 288 Ivell (ref_54) 2014; 155 Hall (ref_39) 2008; 10 Ali (ref_57) 2018; 8 Elmageed (ref_59) 2018; 226 Steinbichler (ref_19) 2017; 44 Melne (ref_2) 2016; 15 Lu (ref_36) 2016; 76 Montgomery (ref_5) 2008; 68 Lu (ref_41) 2018; 70 Holzbeierlein (ref_10) 2004; 164 ref_44 Debes (ref_7) 2004; 351 Chuang (ref_37) 2018; 20 Chen (ref_6) 2004; 10 Agarwal (ref_11) 2010; 6 Dong (ref_53) 2017; 23 Wang (ref_27) 2020; 10 Moroz (ref_16) 2013; 34 Shephard (ref_30) 2017; 3 |
References_xml | – volume: 130 start-page: 2240 year: 2012 ident: ref_34 article-title: ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration publication-title: Int. J. Cancer doi: 10.1002/ijc.26224 – volume: 527 start-page: 329 year: 2015 ident: ref_20 article-title: Tumour exosome integrins determine organotropic metastasis publication-title: Nature doi: 10.1038/nature15756 – volume: 11 start-page: 299 year: 2014 ident: ref_3 article-title: Closing the Controversies Gap in Prostate Cancer publication-title: Nat. Rev. Clin. Oncol. doi: 10.1038/nrclinonc.2014.87 – volume: 78 start-page: 2 year: 2018 ident: ref_15 article-title: Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression publication-title: Prostate doi: 10.1002/pros.23446 – ident: ref_28 doi: 10.3390/cancers12071870 – volume: 18 start-page: 68 year: 2016 ident: ref_55 article-title: Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification publication-title: Breast Cancer Res. doi: 10.1186/s13058-016-0725-1 – ident: ref_31 doi: 10.3390/cells9030564 – volume: 23 start-page: 3461 year: 2017 ident: ref_53 article-title: HMGA2-FOXL2 axis regulates metastases and epithelial-to-mesenchymal transition of chemoresistant gastric cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-2180 – volume: 14 start-page: 1136 year: 2016 ident: ref_42 article-title: Exosome-mediated transfer of alphavbeta3 integrin from tumorigenic to nontumorigenic cells promotes a migratory phenotype publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-16-0058 – volume: 7 start-page: 523 year: 2009 ident: ref_33 article-title: Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP publication-title: Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-08-0400 – ident: ref_44 doi: 10.1371/journal.pone.0024234 – volume: 23 start-page: 630 year: 2011 ident: ref_56 article-title: The role of beta3-integrins in tumor angiogenesis: Context is everything publication-title: Curr. Opin. Cell Biol. doi: 10.1016/j.ceb.2011.03.014 – volume: 164 start-page: 217 year: 2004 ident: ref_10 article-title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)63112-4 – ident: ref_52 doi: 10.1371/journal.pone.0135128 – volume: 76 start-page: 5163 year: 2016 ident: ref_36 article-title: Alphavbeta6 integrin promotes castrate-resistant prostate cancer through JNK1-mediated activation of androgen receptor publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-16-0543 – volume: 1 start-page: 34 year: 2001 ident: ref_12 article-title: The development of androgen-independent prostate cancer publication-title: Nat. Rev. Cancer doi: 10.1038/35094009 – volume: 14 start-page: 316 year: 2016 ident: ref_14 article-title: Current understanding of resistance to abiraterone and enzalutamide in advanced prostate cancer publication-title: Clin. Adv. Hematol. Oncol. – ident: ref_21 doi: 10.3390/cells9040861 – volume: 7 start-page: 40464 year: 2017 ident: ref_48 article-title: Integrin beta4 promotes cell invasion and epithelial-mesenchymal transition through the modulation of Slug expression in hepatocellular carcinoma publication-title: Sci. Rep. doi: 10.1038/srep40464 – volume: 70 start-page: 7 year: 2020 ident: ref_1 article-title: Cancer statistics, 2020 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21590 – volume: 34 start-page: 2017 year: 2013 ident: ref_16 article-title: High circulating estrogens and selective expression of ERbeta in prostate tumors of Americans: Implications for racial disparity of prostate cancer publication-title: Carcinogenesis doi: 10.1093/carcin/bgt156 – volume: 18 start-page: 533 year: 2018 ident: ref_35 article-title: Every step of the way: Integrins in cancer progression and metastasis publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-018-0038-z – volume: 69 start-page: 16 year: 2009 ident: ref_8 article-title: Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-2764 – volume: 28 start-page: 1003 year: 2019 ident: ref_32 article-title: Genetic ancestry analysis reveals misclassification of commonly used cancer cell lines publication-title: Cancer Epidemiol. Biomark. Prev. doi: 10.1158/1055-9965.EPI-18-1132 – volume: 39 start-page: 898 year: 2016 ident: ref_49 article-title: Highly expressed integrin-alpha8 induces epithelial to mesenchymal transition-like features in multiple myeloma with early relapse publication-title: Mol. Cells doi: 10.14348/molcells.2016.0210 – volume: 66 start-page: 2815 year: 2006 ident: ref_9 article-title: Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-4000 – volume: 20 start-page: 10 year: 2018 ident: ref_37 article-title: Blockade of ITGA2 induces apoptosis and inhibits cell migration in gastric cancer publication-title: Biol. Proced. Online doi: 10.1186/s12575-018-0073-x – volume: 78 start-page: 165 year: 2019 ident: ref_46 article-title: Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling publication-title: Matrix Biol. doi: 10.1016/j.matbio.2018.05.002 – volume: 8 start-page: 16335 year: 2018 ident: ref_57 article-title: Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients publication-title: Sci. Rep. doi: 10.1038/s41598-018-34637-8 – volume: 38 start-page: 485 year: 2019 ident: ref_26 article-title: Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway publication-title: J. Exp. Clin. Cancer Res. doi: 10.1186/s13046-019-1496-1 – volume: 10 start-page: 308 year: 2020 ident: ref_27 article-title: Regulation of integrin subunit Alpha 2 by miR-135b-5p modulates chemoresistance in gastric cancer publication-title: Front. Oncol. doi: 10.3389/fonc.2020.00308 – volume: 68 start-page: 4447 year: 2008 ident: ref_5 article-title: Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-0249 – volume: 44 start-page: 170 year: 2017 ident: ref_19 article-title: The role of exosomes in cancer metastasis publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2017.02.006 – volume: 25 start-page: 234 year: 2015 ident: ref_23 article-title: Integrins and cancer: Regulators of cancer stemness, metastasis, and drug resistance publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2014.12.006 – volume: 4 start-page: 121 year: 2018 ident: ref_13 article-title: Past, current, and future incidence rates and burden of metastatic prostate cancer in the united States publication-title: Eur. Urol. Focus doi: 10.1016/j.euf.2017.10.014 – ident: ref_17 doi: 10.3390/cancers11101418 – volume: 2 start-page: 22097 year: 2013 ident: ref_43 article-title: Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients publication-title: J. Extracell. Vesicles doi: 10.3402/jev.v2i0.22097 – volume: 288 start-page: 17713 year: 2013 ident: ref_45 article-title: Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.445403 – volume: 522 start-page: 106 year: 2015 ident: ref_18 article-title: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase publication-title: Nature doi: 10.1038/nature14492 – volume: 216 start-page: 2883 year: 2019 ident: ref_47 article-title: Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis publication-title: J. Exp. Med. doi: 10.1084/jem.20190158 – volume: 32 start-page: 983 year: 2014 ident: ref_29 article-title: Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes publication-title: Stem Cells doi: 10.1002/stem.1619 – volume: 86 start-page: 9906 year: 1989 ident: ref_25 article-title: The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.86.24.9906 – volume: 2015 start-page: 481493 year: 2015 ident: ref_58 article-title: Extracellular vesicles from caveolin-enriched microdomains regulate hyaluronan-mediated sustained vascular integrity publication-title: Int. J. Cell Biol. doi: 10.1155/2015/481493 – volume: 226 start-page: 526 year: 2018 ident: ref_59 article-title: Prognostic role of BRAF(V600E) cellular localization in melanoma publication-title: J. Am. Coll. Surg. doi: 10.1016/j.jamcollsurg.2017.12.040 – volume: 78 start-page: 2205 year: 2018 ident: ref_22 article-title: Nuclear receptor LRH-1 functions to promote castration-resistant growth of prostate cancer via its promotion of intratumoral androgen biosynthesis publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-2341 – volume: 3 start-page: 288 year: 2017 ident: ref_30 article-title: Prostate cancer exosomes as modulators of the tumor microenvironment publication-title: J. Cancer Metastasis Treat. doi: 10.20517/2394-4722.2017.32 – volume: 351 start-page: 1488 year: 2004 ident: ref_7 article-title: Mechanisms of androgen-refractory prostate cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp048178 – volume: 10 start-page: 33 year: 2004 ident: ref_6 article-title: Molecular determinants of resistance to antiandrogen therapy publication-title: Nat. Med. doi: 10.1038/nm972 – volume: 77 start-page: 41 year: 2019 ident: ref_40 article-title: Prostate cancer sheds the alphavbeta3 integrin in vivo through exosomes publication-title: Matrix Biol. doi: 10.1016/j.matbio.2018.08.004 – volume: 24 start-page: 243 year: 1993 ident: ref_51 article-title: Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands publication-title: Hum. Pathol. doi: 10.1016/0046-8177(93)90033-D – volume: 15 start-page: 41 year: 2016 ident: ref_2 article-title: Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: A systematic review publication-title: Mol. Cancer doi: 10.1186/s12943-016-0523-5 – volume: 13 start-page: 208 year: 2014 ident: ref_38 article-title: Induction of integrin alpha2 in a highly bone metastatic human prostate cancer cell line: Roles of RANKL and AR under three-dimensional suspension culture publication-title: Mol. Cancer doi: 10.1186/1476-4598-13-208 – volume: 6 start-page: 665 year: 2010 ident: ref_11 article-title: Abiraterone acetate: A promising drug for the treatment of castration-resistant prostate cancer publication-title: Future Oncol. doi: 10.2217/fon.10.48 – volume: 15 start-page: 657 year: 2008 ident: ref_24 article-title: Integrins in prostate cancer progression publication-title: Endocr. Relat. Cancer doi: 10.1677/ERC-08-0019 – volume: 95 start-page: 1028 year: 2002 ident: ref_4 article-title: Metastatic prostate carcinoma to bone: Clinical and pathologic features associated with cancer-specific survival publication-title: Cancer doi: 10.1002/cncr.10788 – volume: 8 start-page: 3 year: 2009 ident: ref_50 article-title: Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer publication-title: J. Carcinog. doi: 10.4103/1477-3163.48453 – volume: 10 start-page: 797 year: 2008 ident: ref_39 article-title: Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase publication-title: Neoplasia doi: 10.1593/neo.08380 – volume: 155 start-page: 676 year: 2014 ident: ref_54 article-title: Proper application of antibodies for immunohistochemical detection: Antibody crimes and how to prevent them publication-title: Endocrinology doi: 10.1210/en.2013-1971 – volume: 70 start-page: 20 year: 2018 ident: ref_41 article-title: Exosomal alphavbeta6 integrin is required for monocyte M2 polarization in prostate cancer publication-title: Matrix Biol. doi: 10.1016/j.matbio.2018.03.009 |
SSID | ssj0000331767 |
Score | 2.4283395 |
Snippet | Although integrin alpha 2 subunit (ITGA2) mediates cancer progression and metastasis, its transfer by exosomes has not been investigated in prostate cancer... |
SourceID | pubmedcentral proquest gale crossref |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 2300 |
SubjectTerms | Androgen receptors Androgens Cancer cells Cancer therapies Castration Cell adhesion & migration Cell culture Cell growth Cell proliferation Ectopic expression Exosomes Experiments Health aspects Lymph nodes Mesenchyme Metastases Metastasis Methyl-β-Cyclodextrin Phenotypes Physiological aspects Prostate cancer Proteins Tumors |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swELcYSGgvaDCmdQPkSXvYSyBxnDh-mqAqgklF1QQSb1H8VZBK0jUFjX-Bv5o71y20Ejz74yzf-X6-8_mOkJ9GZ1wDbkSMKzRQpI4KmShgCOCLi1VSVOga6F_kZ1f8z3V2HRxubQirnOtEr6hNo9FHfsQA13P8ui1_j_9FWDUKX1dDCY0PZANUcAHG18ZJ72Lwd-FliVPAx1zMcvqkYN8fadzMSZsw_8QUL8HRqlJeDZR8hTynn8hWuDLS4xmPt8marXfIZj88in8mT73_Tdvc2Tbq-7ob1lCPQM5OaOPo-XRYMTrwYXe2pf3b4YzptKoNPa8fKvSXYccBfgCB4bTrF0-7djRqqXqkWN4DSA1pb4w_OEYgskCqBfm-ebyDlXlqPvRrl1yd9i67Z1EosRBpLtk0yiutjZXGJYBKDtO9qwx0ZJVoxguTKmGE1oljinEhVGIzJ2JnKi4LAD5pXfqFrNdNbb8SmjOhtBCwWWDhpRmvCq6tkHFhpFRxKjvkcL7TpQ75x7EMxqgEOwRZU66wpkN-LQaMZ6k33u66h6wr8VDCnBqOiC6P8fKVS1BJ0DxnaRmOaFu-CFSH_Fg040gMO6ttc-_75Nxn6esQsSQKixVheu7llvr2xqfpFhzuPkn67X3i38lHhiY8ZtnN9sj6dHJv9-GeM1UHQZifATOjAWM priority: 102 providerName: ProQuest |
Title | Exosomes-Mediated Transfer of Itga2 Promotes Migration and Invasion of Prostate Cancer Cells by Inducing Epithelial-Mesenchymal Transition |
URI | https://www.proquest.com/docview/2435602549 https://www.proquest.com/docview/2436400955 https://pubmed.ncbi.nlm.nih.gov/PMC7466113 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdbC2MvY90Hy9YGDfawF3eWLFvWQxltSNcOXMJYIG_G-nBacO0uTkvzL-yv3p3ipEvoYM-SrLPupN-dPn5HyCdrYmEANwIuNAYoygSpYhoUAvhShpqlBW4NZBfJ2Vh8n8STh3RA3QC2j4Z2mE9qPKsO738tvsKEP8KIE0L2LwbHZ9Yy7k-NIH7fBViSOEuzztf3y3IEUOkzyvJQ8iBJlFhS_Tz2jQ2U2l6rt-9P_gVIpy_Ji86TpMdL1e-RJ65-RZ5l3Vn5a_J7eN-0zbVrg8yn43CWemAq3Yw2JT2fTwtOR_42nmtpdjVd2gItakvP67sCt9Gw4gjfhUBzOvDC04GrqpbqBcWsH9DVlA5v8GFHBZYMXbVg9peLa5DM9-ZvhL0h49Phz8FZ0GVeCIxQfB4khTHWKVsyAKsSWeB1DEtnwQwXqY20tNIYVnLNhZSaubiUYWkLoVLAQ-XK6C3ZqZvavSM04VIbKWGwIPCLYlGkwjipwtQqpcNI9cjhaqRz09GSY3aMKofwBFWTb6mmRz6vG9wsGTn-XXUfVZej9cA3Dcwckx-jT5YoWKmgeKXSfGV4OQchE6QIAMk-rouxJd5Gq11z6-skwpP39YjcMIW1RMjavVlSX1169m4pwCVi0fv__40P5DnHKB-JeON9sjOf3boDcIXmuk92T4YXox998vTbhPW9wf8BZD8MFA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFVSCbggniJQYJFA4mJqr9de7wGhElIltIki1Eq9Ge_DaaXUDnEK5Bf4GL6RmbUdSCS49byPWe28dmbnQcgroyOuQW94jCs0UKT2EhkoQAjol9xXQZKha2A0jgen_NNZdLZDfrW5MBhW2cpEJ6hNqdFHvs9Ar8eYui3fz7962DUKf1fbFho1WRzZ1Xcw2ap3w4-A39eMHfZPegOv6SrgaS7Z0oszrY2VJg9AEOdY4VxFIBayQDOemFAJI7QOcqYYF0IFNsqFn5uMywRkvbR5CPveILs8BFOmQ3Y_9MeTz2uvjh-CPo5FXUMoDKW_rxF5iypg7kvL31B_20pgOzDzL013eJfcaZ6o9KCmqXtkxxb3yc1R8wn_gPzs_yir8tJW3sj1-bCGOo2X2wUtczpcTjNGJy7Mz1Z0dDGtiYxmhaHD4luG_jmcOMGEE1hOe-7wtGdns4qqFcV2IgBqSvtzzBiZAYsAqAr46Xx1CSdz0Fyo2UNyei2X_4h0irKwjwmNmVBaCLgssCjDiGcJ11ZIPzFSKj-UXfK2velUN_XOse3GLAW7B1GTbqGmS96sF8zrUh__nrqHqEtRCMCeGlhSpwf42IsliEAYblGaNiKhSv8QcJe8XA_jSgxzK2x55ebE3FUF7BKxQQrrE2E58M2R4uLclQUXHN5aQfjk_8BfkFuDk9FxejwcHz0ltxm6D7DCb7RHOsvFlX0Gb6ylet4QNiVfrpuXfgMiMz66 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFVSqeKCykukFFgkkLiY2Ou113tAqKSJGkqiCFGpN-N9OK2U2mmcAvkFPomvY2btBBIJbj3vY1Y7r53ZeRDyyuiIa9AbHuMKDRSpvUQGChAC-iX3VZBk6BoYjuKTM_7xPDrfIb9WuTAYVrmSiU5Qm1Kjj7zDQK_HmLotO3kTFjE-7r-fXXvYQQp_WlftNGoSObXL72C-Ve8Gx4Dr14z1e1-6J17TYcDTXLKFF2daGytNHoBQzrHauYpARGSBZjwxoRJGaB3kTDEuhApslAs_NxmXCch9afMQ9r1DdgVYRX6L7H7ojcaf1x4ePwTdHIu6nlAYSr-jEZHzKmDue8vfUIXbCmE7SPMvrdffJ_ea5yo9qunrPtmxxQOyN2w-5B-Sn70fZVVe2cobup4f1lCn_XI7p2VOB4tJxujYhfzZig4vJzXB0awwdFB8y9BXhxPHmHwCy2nXHZ527XRaUbWk2FoEQE1ob4bZI1NgFwBVAW9dLK_gZA6aCzt7RM5u5fIfk1ZRFvYJoTETSgsBlwXWZRjxLOHaCuknRkrlh7JN3q5uOtVN7XNswTFNwQZC1KRbqGmTN-sFs7rsx7-nHiLqUhQIsKcG9tTpET78YgniEIZXKE0b8VClf4i5TV6uh3ElhrwVtrxxc2LuKgS2idgghfWJsDT45khxeeFKhAsO764gPPg_8BdkD3go_TQYnT4ldxl6ErDYb3RIWov5jX0Gz62Fet7QNSVfb5uVfgOY_ELv |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes-Mediated+Transfer+of+Itga2+Promotes+Migration+and+Invasion+of+Prostate+Cancer+Cells+by+Inducing+Epithelial-Mesenchymal+Transition&rft.jtitle=Cancers&rft.au=Gaballa%2C+Rofaida&rft.au=Ali%2C+Hamdy+E.+A.&rft.au=Mahmoud%2C+Mohamed+O.&rft.au=Rhim%2C+Johng+S.&rft.date=2020-08-15&rft.issn=2072-6694&rft.eissn=2072-6694&rft.volume=12&rft.issue=8&rft.spage=2300&rft_id=info:doi/10.3390%2Fcancers12082300&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_cancers12082300 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon |